Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for post-operative pain in orthognathic surgery
NCT03318757Phase 4Withdrawn
- Sponsor
- Boston University
- Start
- Sep 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Boston University. Planned start Sep 2020; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03318757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318757.